In U.S. Biosimilars Run Into More Roadblocks

In a recent op-ed in the Wall Street Journal Peter Bach asks whether it's time to give up on biosimilars.

One might counter by saying don't throw out the baby with the bathwater. While biosimilar uptake has not been as robust as was hoped initially, it's premature to throw in the towel.